Faeth Releases PIKTOR Phase 2 Results in Endometrial Cancer
Faeth Therapeutics announced preliminary Phase 2 data for PIKTOR in combination with paclitaxel for advanced endometrial cancer, highlighting top-line results and the presentation of efficacy-evaluable analyses.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed